Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-10-02
2007-10-02
Kam, Chih-Min (Department: 1656)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S236100, C424S009100, C514S002600, C514S012200, C530S350000, C435S252700
Reexamination Certificate
active
11056382
ABSTRACT:
Disclosed is a method for treating abnormalities of the first metatarsophalangeal joint of the foot of a mammal comprising administering a therapeutically effective amount of neuromuscular toxin to the mammal. Preferred embodiments include administering toxins capable of interfering with the connection between muscle and nerve, e.g. botulinum toxin, to the patient to treat such abnormalities as hallux abductovalgus, hallux varus, hallux limitus, and hallux rigidus.
REFERENCES:
patent: 4932936 (1990-06-01), Dykstra et al.
patent: 5053005 (1991-10-01), Borodic et al.
patent: 5766605 (1998-06-01), Sanders et al.
patent: 6087327 (2000-07-01), Pearce et al.
patent: 6290961 (2001-09-01), Aoki et al.
patent: 6319505 (2001-11-01), Aoki et al.
patent: 6333037 (2001-12-01), Aoki et al.
patent: 6632433 (2003-10-01), Aoki et al.
patent: 2003/0224020 (2003-12-01), Zabudkin et al.
patent: 2005/0123567 (2005-06-01), First
patent: WO 95/17904 (1995-07-01), None
Sherman A L, Willick S P, Cardenas D D , “Management of Focal Dystonia of the Extensor Hallucis Longus Muscle with Botulinum Toxin Injection: A Case Report,” Arch Phys Med Rehabil, 1998, 1303-1305, 79.
Yelnik A P, Colle F M, Bonan I V, Lamotte D R, “Disabling Overactivity of the Extensor Hallucis Longus after Stroke: Clinical Expression and Efficacy of Botulinum Toxin Type A,” Arch Phys Med Rehabil, 2003, 147-149, 84.
Yelnik AP, Bonan I V: “Post Stroke Hemiplegia: Lower Limb Benefit from Botulinum Toxin (Review),” Annales De Réadaptation Et De Médecine Physique, 2003, 281-284, 46.
Ferrari J: “Bunions,” Clin Evid., 2003, 1259-1270, 10.
Koman, et al., “Botulinum Toxin Type A Neuromuscular Blockade in the Treatment of Equinus Foot Deformity in Cerebral Palsy: A Multicenter, Open-Label Clinical Trial,” Pediatrics 2001; 108; 1062-1071 [online] [retrieved on May 10, 2005]<URL: www.pediatrics.org>.
Ubhi, T. et al., “Randomised Double Blind Placebo Controlled Trial of the Effect of Botulinum Toxin on Walking in Cerebral Palsy,” Arch. Dis. Child. Dec. 2000; 83:481-487, Downloaded on Apr. 12, 2003 from website: http://adc.bmj.com.
Tamura, B M. et al., “Plantar Hyperhidrosis and Pitted Keratoloysis Treated with Botulinum Toxin Injection,” Dermatol Surg. 30(12 Pt 2): 1510, 2004. Abstract downloaded on May 1, 2006 from website: http://www.ncbi.nlm.nih.gov.
Suputtitada, A., “Local Botulinum Toxin Type A Injections in the Treatment of Spastic Toes,” Am. J. Phys. Med. Rehabil 81(10);770, 2002.
Simpson, LL., “Current Concepts on the Mechanism of Action of Clostridial Neurotoxins,” Das Gupta BR (ed): Botulinum and Tetanus Neurotoxins. New York, Plenum Press: 5, 1993.
Sherman, A L. et al., “Management of Focal Dystonia of the Extensor Hallucis Longus Muscle with Botulinum Toxin Injection: A Case Report,” Arch Phys Med Rehabil, 1998, 1303-1305, 79.
Placzek, R. et al., “Botulinum Toxin A in Orthopedic Pain Therapy,” Schmerz 18(6):498, 2004. Abstract downloaded on May 1, 2006 from website: http://www.ncbi.nlm.nih.gov.
Hoffmeyer, P. et al., “Muscle is Hallux Valgus,” Clin Orthop Relat Res. , Jul. 1988; (232):112-8. Abstract downloaded on Jan. 8, 2007 from website: http://www.ncbi.nlm.nih.gov.
Hambleton, P. et al., “Botulinum Neurotoxins: Origin, Structure, Molecular Actions and Antibodies,” Moore AP, ed. Handbook of Botulinum Toxin Treatment, Oxford: Blackwell Science Ltd: 16, 1995.
Giladi, N. et al., “The Use of Botulinum Toxin to Treat “Striatal” Toes,” J Neurol Neurosurg Psychiatry, 1994.
Ferrari J., “Interventions for Treating Hallux Valgus (Abductovalgus) and Bunions,” Cochrane Database Syst. Rev. 2004; (1): CD000964. Downloaded on Aug. 3, 2006 from website: http://www.ncbi.nlm.nih.gov.
Biglan, A W. et al. “Management of Strabismus with Botulinum Toxin,” A. Ophthalmology 96:935-43, 1989. Abstract downloaded from website: http://www.ncbi.nlm.nih.gov.
Bhidayasiri, R. et al., “Expanding Use of Botulinum Toxin,” J. Neurol. Sci. 235(1-2):1, 2005. Abstract downloaded on May 1, 2006 from website: http://www.ncbi.nlm.nih.gov.
Babcock, M S. et al., “Treatment of Pain Attributed to Plantar Fasciitis with Botulinum Toxin A: A Short-Term, Randomized, Placebo-Controlled, Double-Blind Study,” Am. J. Phys. Med. Rehabil. 84(9):649, 2005. Abstract downloaded on May 1, 2006 from website: http://www.ncbi.nlm.nih.gov.
Arinci, Incel N. et al., “Muscle Imbalance in Hallux Valgus: An Electromyographic Study,” Am. J. Phys. Med. Rehabil., May 2003; 82(5):345-9. Abstract downloaded on Jan. 8, 2007 from website: http://www.ncbi.nlm.nih.gov.
Aoki, K R., “Evidence for Antinociceptive Activity for Botulinum Toxin Type A in Pain Management,” Headache Jul. 2003; 43 Suppl 1:S9-15. Abstract downloaded on May 1, 2006 from website: http://www.ncbi.nlm.nih.gov.
PCT International Search Report and Written Opinion mailed Oct. 11, 2005.
PCT Written Opinion of the International Examining Authority mailed Oct. 3, 2006.
Kam Chih-Min
Knobbe Martens Olson & Bear LLP
Radovic Philip
LandOfFree
Methods of treating abnormalities of the first... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating abnormalities of the first..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating abnormalities of the first... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3825430